MEDNAX (MD) Tops Q2 EPS by 14c

MEDNAX (NYSE: MD) reported Q2 EPS of $1.02, $0.14 better than the analyst estimate of $0.88. Revenue for the quarter came in at $677 million versus the consensus estimate of $677.02 million.

MEDNAX sees Q315 EPS of $1.07-$1.11, versus the consensus of $0.97.

For earnings history and earnings-related data on MEDNAX (MD) click here.

You May Also Be Interested In

• BayCom Corp (BCML) Misses Q1 EPS by 4c
• United Bancshares, Inc. (UBOH) Reports Q1 EPS of $0.61
• Independent Bank (INDB) Misses Q1 EPS by 3c